These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 7849715)
1. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Carey AH; Waterworth D; Patel K; White D; Little J; Novelli P; Franks S; Williamson R Hum Mol Genet; 1994 Oct; 3(10):1873-6. PubMed ID: 7849715 [TBL] [Abstract][Full Text] [Related]
2. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'-UTR in patients with polycystic ovarian syndrome. Marszalek B; Laciński M; Babych N; Capla E; Biernacka-Lukanty J; Warenik-Szymankiewicz A; Trzeciak WH Gynecol Endocrinol; 2001 Apr; 15(2):123-8. PubMed ID: 11379008 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Carey AH; Chan KL; Short F; White D; Williamson R; Franks S Clin Endocrinol (Oxf); 1993 Jun; 38(6):653-8. PubMed ID: 8334753 [TBL] [Abstract][Full Text] [Related]
4. A polymorphism in the CYP17 gene is associated with prostate cancer risk. Gsur A; Bernhofer G; Hinteregger S; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M Int J Cancer; 2000 Aug; 87(3):434-7. PubMed ID: 10897051 [TBL] [Abstract][Full Text] [Related]
5. Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study. Echiburú B; Pérez-Bravo F; Maliqueo M; Sánchez F; Crisosto N; Sir-Petermann T Metabolism; 2008 Dec; 57(12):1765-71. PubMed ID: 19013303 [TBL] [Abstract][Full Text] [Related]
6. [Polymorphism in CYP11alpha and CYP17 genes and the etiology of hyperandrogenism in patients with polycystic ovary syndrome]. Pérez MS; Cerrone GE; Benencia H; Márquez N; De Piano E; Frechtel GD Medicina (B Aires); 2008; 68(2):129-34. PubMed ID: 18499961 [TBL] [Abstract][Full Text] [Related]
7. Hypersecretion of androgens by polycystic ovaries: the role of genetic factors in the regulation of cytochrome P450c17 alpha. Franks S; White D; Gilling-Smith C; Carey A; Waterworth D; Williamson R Baillieres Clin Endocrinol Metab; 1996 Apr; 10(2):193-203. PubMed ID: 8773744 [TBL] [Abstract][Full Text] [Related]
8. Association between CYP17 gene polymorphism and risk of breast cancer in young women. Bergman-Jungeström M; Gentile M; Lundin AC; Wingren S Int J Cancer; 1999 Aug; 84(4):350-3. PubMed ID: 10404084 [TBL] [Abstract][Full Text] [Related]
9. Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1. Wickenheisser JK; Nelson-DeGrave VL; Quinn PG; McAllister JM Mol Endocrinol; 2004 Mar; 18(3):588-605. PubMed ID: 14684846 [TBL] [Abstract][Full Text] [Related]
10. Frequency of a polymorphism in the regulatory region of the 17 alpha-hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states. Techatraisak K; Conway GS; Rumsby G Clin Endocrinol (Oxf); 1997 Feb; 46(2):131-4. PubMed ID: 9135692 [TBL] [Abstract][Full Text] [Related]
11. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. Govind A; Obhrai MS; Clayton RN J Clin Endocrinol Metab; 1999 Jan; 84(1):38-43. PubMed ID: 9920059 [TBL] [Abstract][Full Text] [Related]
12. No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk. dos Santos A; Ribeiro ML; Mesquita JC; Carvalho-Salles AB; Hackel C Prostate Cancer Prostatic Dis; 2002; 5(1):28-31. PubMed ID: 15195127 [TBL] [Abstract][Full Text] [Related]
13. The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population. Tsujino T; Ohara N; Yoshida S; Kennedy S; Takemura N; Deguchi M; Maruo T Gynecol Endocrinol; 2006 Feb; 22(2):87-91. PubMed ID: 16603433 [TBL] [Abstract][Full Text] [Related]
14. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect. Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764 [TBL] [Abstract][Full Text] [Related]
15. Combined 17alpha-Hydroxylase/17,20-lyase deficiency caused by Phe93Cys mutation in the CYP17 gene. Di Cerbo A; Biason-Lauber A; Savino M; Piemontese MR; Di Giorgio A; Perona M; Savoia A J Clin Endocrinol Metab; 2002 Feb; 87(2):898-905. PubMed ID: 11836339 [TBL] [Abstract][Full Text] [Related]
16. Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls. Song G; Gu L; Tian F; Bao Q; Tang Z; Wang S Medicina (Kaunas); 2013; 49(2):51-5. PubMed ID: 23888338 [TBL] [Abstract][Full Text] [Related]
17. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss. Sata F; Yamada H; Yamada A; Kato EH; Kataoka S; Saijo Y; Kondo T; Tamaki J; Minakami H; Kishi R Mol Hum Reprod; 2003 Nov; 9(11):725-8. PubMed ID: 14561815 [TBL] [Abstract][Full Text] [Related]
19. Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. Kahsar-Miller M; Boots LR; Bartolucci A; Azziz R Fertil Steril; 2004 Oct; 82(4):973-5. PubMed ID: 15482786 [TBL] [Abstract][Full Text] [Related]
20. Novel mutation of the CYP17 gene in two unrelated patients with combined 17alpha-hydroxylase/17,20-lyase deficiency: demonstration of absent enzyme activity by expressing the mutant CYP17 gene and by three-dimensional modeling. Patocs A; Liko I; Varga I; Gergics P; Boros A; Futo L; Kun I; Bertalan R; Toth S; Pazmany T; Toth M; Szücs N; Horanyi J; Glaz E; Racz K J Steroid Biochem Mol Biol; 2005 Nov; 97(3):257-65. PubMed ID: 16176874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]